Amarin (AMRN) Competitors

Chimerix (NASDAQ:CMRX) and Amarin (NASDAQ:AMRN) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, dividends, institutional ownership, media sentiment, risk, profitability, analyst recommendations, valuation and community ranking.

Does the MarketBeat Community prefer CMRX or AMRN?

Amarin received 448 more outperform votes than Chimerix when rated by MarketBeat users. Likewise, 73.58% of users gave Amarin an outperform vote while only 63.46% of users gave Chimerix an outperform vote.

Company	Underperform	Outperform
Chimerix	Outperform Votes 396 63.46%	Underperform Votes 228 36.54%
Amarin	Outperform Votes 844 73.58%	Underperform Votes 303 26.42%

Does the media favor CMRX or AMRN?

In the previous week, Amarin had 10 more articles in the media than Chimerix. MarketBeat recorded 17 mentions for Amarin and 7 mentions for Chimerix. Chimerix's average media sentiment score of 0.72 beat Amarin's score of -0.18 indicating that Chimerix is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Chimerix	1 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Amarin	1 Very Positive mention(s)	1 Positive mention(s)	9 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Neutral

Do insiders & institutionals have more ownership in CMRX or AMRN?

45.4% of Chimerix shares are held by institutional investors. Comparatively, 22.3% of Amarin shares are held by institutional investors. 13.1% of Chimerix shares are held by company insiders. Comparatively, 2.0% of Amarin shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Do analysts rate CMRX or AMRN?

Chimerix currently has a consensus price target of $8.53, indicating a potential upside of 0.87%. Given Chimerix's higher possible upside, analysts clearly believe Chimerix is more favorable than Amarin.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Chimerix	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Amarin	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Is CMRX or AMRN more profitable?

Chimerix has a net margin of 0.00% compared to Amarin's net margin of -16.33%. Amarin's return on equity of -7.22% beat Chimerix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Chimerix	N/A	-50.78%	-44.94%
Amarin	-16.33%	-7.22%	-4.96%

Which has more volatility and risk, CMRX or AMRN?

Chimerix has a beta of 0.32, suggesting that its share price is 68% less volatile than the S&P 500. Comparatively, Amarin has a beta of 1.82, suggesting that its share price is 82% more volatile than the S&P 500.

Which has stronger earnings and valuation, CMRX or AMRN?

Amarin has higher revenue and earnings than Chimerix. Chimerix is trading at a lower price-to-earnings ratio than Amarin, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Chimerix	$159K	4,785.27	-$82.10M	-$0.94	-9.00
Amarin	$228.61M	0.74	-$59.11M	-$0.20	-2.07

Summary

Amarin beats Chimerix on 12 of the 18 factors compared between the two stocks.